HNGE affiliate sells Class A shares

Insight Venture Partners reported planned dispositions of Hinge Health Class A Common Stock.

Rhea-AI Filing Summary

Insight Venture Partners reported planned dispositions of Hinge Health Class A Common Stock. The excerpt lists multiple proposed sales executed through Raymond James & Associates as broker, including 06/16/2026 (5,195 shares for $365,518.12) and additional sales on 06/22/2026, 06/23/2026, 06/24/2026, and 06/25/2026 with stated share counts and proceeds.

Insights

Securities Compliance Counsel

Form 144 disclosures list multiple affiliate resale notices with transaction dates and proceeds.

These entries show proposed sales by Insight Venture Partners entities of Class A Common shares of Hinge Health, with broker information (Raymond James & Associates) and specific per‑trade proceeds such as $3,008,045.57 on 06/24/2026.

Cash‑flow treatment and whether transactions were completed are not stated; subsequent filings or trade confirmations would show settlement outcomes.

Key Figures

Trade 06/16/2026: 5,195 shares / $365,518.12 Trade 06/22/2026: 17,776 shares / $1,261,280.08 Trade 06/23/2026: 8,910 shares / $625,611.20 +2 more

5 metrics

Trade 06/16/2026 5,195 shares / $365,518.12 <date>06/16/2026</date> proposed sale by Insight Venture Partners (Delaware) X, L.P.

Trade 06/22/2026 17,776 shares / $1,261,280.08 <date>06/22/2026</date> proposed sale by Insight Venture Partners (Delaware) X, L.P.

Trade 06/23/2026 8,910 shares / $625,611.20 <date>06/23/2026</date> proposed sale by Insight Venture Partners (Delaware) X, L.P.

Trade 06/24/2026 42,240 shares / $3,008,045.57 <date>06/24/2026</date> proposed sale by Insight Venture Partners (Delaware) X, L.P.

Trade 06/25/2026 42,062 shares / $3,021,040.06 <date>06/25/2026</date> proposed sale by Insight Venture Partners (Cayman) X, L.P.

Key Terms

Form 144, Class A Common, stock conversion before IPO

3 terms

Form 144 regulatory

"Entries are listed under the filing type showing proposed resale notices and trade dates"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Class A Common financial

"Security column labels the instrument being sold as CLASS A COMMON"

stock conversion before IPO financial

"Phrase 'STOCK CONVERSION BEFORE IPO' appears adjacent to SERIES B PREFERRED"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Form 144 filing show?

The filing lists proposed resale notices for Class A Common shares by Insight Venture Partners entities. It includes trade dates and proceeds such as $365,518.12 on 06/16/2026 and larger amounts on later dates.

Who is the broker handling the Hinge Health (HNGE) sales?

The excerpt names Raymond James & Associates as the broker-dealer for these transactions, with an address in St. Petersburg, Florida. The broker is listed alongside the Class A Common security details.

How many shares were listed in the largest trade shown?

The largest single trade shown in the excerpt is 42,240 shares on 06/24/2026 with proceeds of $3,008,045.57. The table lists several additional trades with their share counts and dollar amounts.

Do these entries confirm the sales settled?

These entries are proposed disposition notices and list intended sale dates and proceeds. The excerpt does not confirm settlement or post-trade holdings; settlement status is not provided in the provided text.

Which Insight Venture entities are named in the HNGE excerpt?

The excerpt names Insight Venture Partners (Delaware) X, L.P. and Insight Venture Partners (Cayman) X, L.P. as selling holders, each with specific trade dates, share counts, and proceeds shown in the table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 05:20 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Delaware) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
CLASS A COMMON	RAYMOND JAMES & ASSOCIATES 880 CARILLON PKWY ST. PETERSBURG FL 33716	116183	9294640.00	55883690	06/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
SERIES B PREFERRED	07/03/2018	STOCK CONVERSION BEFORE IPO	HINGE HEALTH, INC.			3678282	07/03/2018	WIRED TO PORTFOLIO COMPANY

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Delaware) X, L.P. 1114 Avenue of the Americas, 36th Floor NEW YORK NY 10036	CLASS A COMMON	06/16/2026	5195	365518.12
Insight Venture Partners (Delaware) X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/22/2026	17776	1261280.08
Insight Venture Partners (Delaware) X, L.P. 1114 AVENUE OF AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/23/2026	8910	625611.20
Insight Venture Partners (Delaware) X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/24/2026	42240	3008045.57
Insight Venture Partners (Cayman) X, L.P. 1114 AVENUE OF THE AMERICAS 36TH FL NEW YORK NY 10036	CLASS A COMMON	06/25/2026	42062	3021040.06

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	MOHAMMED ALSHATRI, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Delaware)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)